Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children

Stephen K Obaro, D. Pugatch, K. Luzuriaga

Research output: Contribution to journalReview article

70 Citations (Scopus)

Abstract

Children infected by HIV-1 are particularly vulnerable to severe, recurrent, or unusual infections by vaccine-preventable pathogens. Routine immunisations seem to be generally safe for HIV-1-infected children, but responses may be suboptimal. Early HIV-1-induced immune attrition associated with viral replication may particularly interfere with the development of memory responses. In high HIV-1 prevalence regions, the accumulation of susceptible hosts may compromise disease-control efforts. Although early control of viral replication through treatment with highly active therapy may preserve immune function and responses to routine childhood vaccines, availability is limited in the areas most affected. In this review, we provide an overview of the immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The possible immunological bases for defective responses are discussed; unanswered questions and the need for further research are delineated.

Original languageEnglish (US)
Pages (from-to)510-518
Number of pages9
JournalLancet Infectious Diseases
Volume4
Issue number8
DOIs
StatePublished - Aug 1 2004

Fingerprint

HIV-1
Vaccines
Immunization
Therapeutics
Infection
Research

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. / Obaro, Stephen K; Pugatch, D.; Luzuriaga, K.

In: Lancet Infectious Diseases, Vol. 4, No. 8, 01.08.2004, p. 510-518.

Research output: Contribution to journalReview article

@article{eafee9cbff8a4ee1a60bf5576c7aa35c,
title = "Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children",
abstract = "Children infected by HIV-1 are particularly vulnerable to severe, recurrent, or unusual infections by vaccine-preventable pathogens. Routine immunisations seem to be generally safe for HIV-1-infected children, but responses may be suboptimal. Early HIV-1-induced immune attrition associated with viral replication may particularly interfere with the development of memory responses. In high HIV-1 prevalence regions, the accumulation of susceptible hosts may compromise disease-control efforts. Although early control of viral replication through treatment with highly active therapy may preserve immune function and responses to routine childhood vaccines, availability is limited in the areas most affected. In this review, we provide an overview of the immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The possible immunological bases for defective responses are discussed; unanswered questions and the need for further research are delineated.",
author = "Obaro, {Stephen K} and D. Pugatch and K. Luzuriaga",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/S1473-3099(04)01106-5",
language = "English (US)",
volume = "4",
pages = "510--518",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "8",

}

TY - JOUR

T1 - Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children

AU - Obaro, Stephen K

AU - Pugatch, D.

AU - Luzuriaga, K.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Children infected by HIV-1 are particularly vulnerable to severe, recurrent, or unusual infections by vaccine-preventable pathogens. Routine immunisations seem to be generally safe for HIV-1-infected children, but responses may be suboptimal. Early HIV-1-induced immune attrition associated with viral replication may particularly interfere with the development of memory responses. In high HIV-1 prevalence regions, the accumulation of susceptible hosts may compromise disease-control efforts. Although early control of viral replication through treatment with highly active therapy may preserve immune function and responses to routine childhood vaccines, availability is limited in the areas most affected. In this review, we provide an overview of the immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The possible immunological bases for defective responses are discussed; unanswered questions and the need for further research are delineated.

AB - Children infected by HIV-1 are particularly vulnerable to severe, recurrent, or unusual infections by vaccine-preventable pathogens. Routine immunisations seem to be generally safe for HIV-1-infected children, but responses may be suboptimal. Early HIV-1-induced immune attrition associated with viral replication may particularly interfere with the development of memory responses. In high HIV-1 prevalence regions, the accumulation of susceptible hosts may compromise disease-control efforts. Although early control of viral replication through treatment with highly active therapy may preserve immune function and responses to routine childhood vaccines, availability is limited in the areas most affected. In this review, we provide an overview of the immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The possible immunological bases for defective responses are discussed; unanswered questions and the need for further research are delineated.

UR - http://www.scopus.com/inward/record.url?scp=4043130376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043130376&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(04)01106-5

DO - 10.1016/S1473-3099(04)01106-5

M3 - Review article

VL - 4

SP - 510

EP - 518

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 8

ER -